Washington, D.C., ÉUA, du 26 au 30 septembre 2016
Point 4.10 de l’ordre du jour provisoire
CD55/14 8 juillet 2016
Original : anglais
Health and Human Rights Journal
December 2016 / Volume 18 / Number 2 / Papers, 171-182
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...(30%) had dolutegravir HIVDR. Malawi urgently requires adequate HIVDR testing capacity.
more
District Level M & E Training and Reference Material for Primary Health Care Programmes
ev Panam Salud Publica. 2020;44;e28. https://doi.org/10.26633/RPSP.2020.28